Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6511 to 6525 of 8314 results

  1. Workplace health: long-term sickness absence and incapacity to work (PH19)

    This guideline has been updated and replaced by NICE guideline NG146.

    Public health guideline
    Published
    25 March 2009

  2. Social and emotional wellbeing in secondary education (PH20)

    This guideline has been updated and replaced by NICE guideline on social, emotional and mental wellbeing in primary and secondary education (NG223).

    Public health guideline
    Published
    23 September 2009

  3. Immunisations: reducing differences in uptake in under 19s (PH21)

    This guideline has been replaced by NICE guideline NG218.

    Public health guideline
    Last updated
    26 September 2017

  4. Mental wellbeing at work (PH22)

    This guideline has been updated and replaced by NICE guideline NG212.

    Public health guideline
    Published
    5 November 2009

  5. Smoking prevention in schools (PH23)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Public health guideline
    Published
    24 February 2010

  6. Rituximab for aggressive non-Hodgkin's lymphoma (TA65)

    After consultation the guidance has been withdrawn because it is no longer relevant to clinical practice. Rituximab is now routinely used outside its licensed indication. See NICE’s guideline on non-Hodgkin’s lymphoma.

    Technology appraisal guidance
    Published
    24 September 2003

  7. Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer (TA831)

    This guidance has been updated and replaced by NICE technology appraisal guidance 887.

    Technology appraisal guidance
    Published
    5 October 2022

  8. The clinical effectiveness and cost effectiveness of technologies for the secondary prevention of osteoporotic fractures in postmenopausal women (TA87)

    This guidance has been updated and replaced NICE technology appraisal guidance 161.

    Technology appraisal guidance
    Published
    26 January 2005

  9. Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer (TA885)

    This guidance has been updated and replaced by NICE technology appraisal guidance 939.

    Technology appraisal guidance
    Published
    3 May 2023

  10. The use of autologous chondrocyte implantation for the treatment of cartilage defects in the knee joints (TA89)

    This guidance has been updated and replaced by NICE technology appraisal guidance 477. 

    Technology appraisal guidance
    Published
    25 May 2005

  11. Immunosuppressive therapy for renal transplantation in adults (TA85)

    This guidance has been updated and replaced by NICE technology appraisal guidance 481.

    Technology appraisal guidance
    Published
    22 September 2004

  12. Hearing disability - hearing aids (TA8)

    This guidance has been withdrawn.

    Technology appraisal guidance
    Published
    23 July 2000

  13. Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome (TA80)

    This guidance has been replaced by recommendations 1.3.4 to 1.3.8 in NICE guideline CG94 and by recommendation 1.3.18 in NICE guideline CG172.

    Technology appraisal guidance
    Published
    28 July 2004

  14. The clinical effectiveness and cost effectiveness of new drugs for bipolar disorder (TA66)

    This guidance has been updated and replaced NICE guideline CG38.

    Technology appraisal guidance
    Published
    24 September 2003

  15. Guidance on the use of photodynamic therapy for age-related macular degeneration (TA68)

    This guidance has been updated and replaced by NICE guideline NG82.

    Technology appraisal guidance
    Published
    24 September 2003